Definitive Contract 75F40122C00199

Proimmune, Inc. was awarded a definitive contract by the Department of Health and Human Services' Food and Drug Administration (FDA) to conduct a comparison of CRISPR-associated protein 9 (Cas9) derived from different organisms. Specifically, the contract calls for Proimmune to perform a dendritic cell-T cell proliferation assay and an antigen presenting assay, also known as major histocompatibility complex class II-associated peptide proteomics assay, to analyze Cas9 proteins. The potential...

This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $14,090 contract is for custom protein production services to support biomedical research and public health initiatives. The award is not associated with a larger contract vehicle and does not have a set-aside designation....

Laboratories Nexelis Canada Inc., doing business as Pairimmune, has been awarded a firm fixed-price purchase order valued at $14.56 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Under this contract, Pairimmune will establish high throughput SARS-CoV-2 binding antibody immunoassay capability and test human serum samples to support the federal government's response to the COVID-19 pandemic. As the prime contractor,...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $14.7 million firm fixed price definitive contract to Laboratories Nexelis Canada Inc., doing business as Pairimmune, to provide high throughput SARS-CoV-2 binding antibody immunoassay testing of clinical samples from COVID-19 vaccine trials. The contract supports assay development and validation for emerging SARS-CoV-2 variants. Per the solicitation, the one-year base period...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $20,827.75 purchase order to Genscript USA Inc. to provide customized protein production using a baculovirus expression system. Performance will take place in Piscataway, New Jersey over a period of approximately three months concluding in mid-December 2023. The firm fixed price contract calls for Genscript to deliver the requested proteins without further...

This is a $79,659.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Proimmune, Inc., a small business. The contract is for a T cell proliferation assay, which is a type of immunology research service. Proimmune has previously provided similar services to the Department of Health and Human Services, including the FDA and National Institutes of Health, such as MHC class II peptide proteomics assays, HLA typing, and analyzing FVIII-derived peptides. The...

This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $96,751.91 contract is for the provision of custom antigens to support assay development work. The award has no set-aside designation. Genscript specializes in supplying a range of molecular biology products and services to various federal agencies, including the Department of Health and Human Services. The...

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for the delivery of custom rabbit monoclonal antibodies to support the development of diagnostic tests for taeniasis and cysticercosis. The award, valued at $49,981.00, was made by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and has a period of performance from September 30, 2024 to April 22, 2025. The original solicitation, a Request for Quotations (RFQ), was...

This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Proteos Inc., a for-profit organization specializing in the production of recombinant proteins. The $24,248.00 contract is for the expression and purification of OTSA and OTSB proteins in insect cells, with a target of 7.5 mg of OTSA and 2.5 mg of OTSB at a purity greater than 90% and low endotoxin levels. The contract has an...

Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...